The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piaggio, E.
Right arrow Articles by Serra, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piaggio, E.
Right arrow Articles by Serra, E.
The Journal of Immunology, 2001, 167: 3422-3426.
Copyright © 2001 by The American Association of Immunologists

Trypanocidal Drug Benznidazole Impairs Lipopolysaccharide Induction of Macrophage Nitric Oxide Synthase Gene Transcription Through Inhibition of NF-{kappa}B Activation1

Eliane Piaggio*,{dagger}, Josiane Sancéau{ddagger}, Silvia Revelli*, Oscar Bottasso2,*, Juana Wietzerbin{ddagger} and Esteban Serra{dagger}

* Facultad de Ciencias Médicas, Instituto de Immunología, Rosario, Argentina; {dagger} Facultad de Ciencias Bioquímicas y Farmacéuticas, Instituto de Biología Molecular y Celular de Rosario Consejo Nacional de Invetigaciones Cientìficas y Técnicas de Argentina, Rosario, Argentina; and {ddagger} Institut National de la Santé et de la Recherche Médicale Unite 365, Institut Curie, Section de Recherche, Paris, France

In murine macrophages, inducible NO synthase II (NOSII) gene expression is promoted at a transcriptional level by LPS and/or IFN-{gamma} with benznidazole (BZL), a trypanocidal drug, acting to down-regulate NOSII gene induction and hence inhibiting NO production. By performing transient transfection experiments, we now report that BZL also inhibited the expression of NOSII gene promoter or multimerized NF-{kappa}B binding site controlled reporter genes. By contrast, no effect was observed on the expression of a reporter gene under the control of the NOSII promoter-derived IFN regulatory factor element. EMSAs demonstrated that BZL inhibited the nuclear availability of NF-{kappa}B in stimulated macrophages. NF-{kappa}B is activated in macrophages by phosphorylation, ubiquitination, and subsequent proteolysis of I{kappa}B. Within this setting, Western blot was also performed to show that BZL blocked I{kappa}B{alpha} degradation. Collectively, these results demonstrate that BZL is able to specifically inhibit macrophage NF-{kappa}B activation after LPS plus IFN-{gamma} stimulation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.